Robot-assisted lung surgery for early-stage lung cancer
Part of Cancer, Lungs & breathing clinical trials.
This trial compares two types of robot-assisted lung surgery for early-stage non-small cell lung cancer. One method uses a fully robotic setup, and the other involves the surgeon helping with part of the procedure. The goal is to see which approach works better for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 120 years old.
- You can speak and understand English.
- You have stage I, II, or IIIa non-small cell lung cancer.
- Your surgeon has confirmed you are a candidate for robotic lung surgery.
- You are not taking blood thinners that cannot be stopped before surgery.
- You do not have a bleeding disorder, systemic blood vessel disease, or vasculitis.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two minimally invasive surgeries for early-stage non-small cell lung cancer: robotic-assisted (RATS) versus video-assisted (VATS). It aims to see which approach is better for removing a lobe or part of a lobe, focusing on recovery and safety.
This study compares two types of minimally invasive surgery—robotic-assisted (da Vinci) and VATS—for people with early-stage non-small cell lung cancer. The goal is to see which approach might work better and help patients recover faster.
This trial studies a new surgical robot that uses only one small opening in the chest to remove a lung segment or lobe. It aims to see if the robot is safe and effective for patients who need this type of surgery.
This trial tests whether robotic-assisted surgery for lung cancer is safe and effective in elderly patients. It may be a good option if you are older and able to undergo surgery.
This trial compares robot-assisted surgery to video-assisted surgery for removing lung cancer. It aims to see which approach works better for patients with early-stage non-small cell lung cancer.
This trial tests whether combining immunotherapy with chemotherapy before robot-assisted lung surgery improves outcomes for patients with stage II–III non-small cell lung cancer. The goal is to shrink the tumor before surgery and then remove it completely using minimally invasive robotic techniques.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.